April 25, 2025

Helping children with cancer with flowers

Helping children with cancer with flowers

From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer. With its campaign “Blumen schenken. Hoffnung spenden.” (Give flowers. Spread hope.) the Hopp Children’s Cancer Center Heidelberg (KiTZ) wants to draw attention to the urgently needed research for improved cancer therapies for children and young people and collect donations for this purpose. This year’s campaign partners are once again the Fachverband Deutscher Floristen e.V. and Fleurop AG.

The Hopp Children’s Cancer Center Heidelberg (KiTZ) is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD) and the University of Heidelberg (Uni HD).

Looking forward to the start of the campaign: f.l. Sabine Reinke (Fleurop AG), Frederike Scheurer (KiTZ Fundraising) and Klaus Götz (Fachverband Deutscher Floristen e.V. Bundesverband). © Marius Stark/KiTZ

Anyone who loves flowers and wants to help seriously ill children can now take part in a very special campaign. Under the motto “Give flowers. Spread hope.” flower stores, garden centers and nurseries throughout Germany will be selling flowers from April 28 to May 24 to benefit children with cancer.

The campaign was initiated by the Hopp Children’s Cancer Center Heidelberg (KiTZ), which wants to draw attention to the situation of affected families and the need for children’s cancer research. “One in five children still dies from cancer and many survivors suffer from the consequences for the rest of their lives. Reliable early detection is also important in order to be able to treat such high-risk patients in good time. There is an urgent need for action in pediatric oncology,” says Stefan Pfister, Director at KiTZ, Head of Department at the German Cancer Research Center (DKFZ) and pediatric oncologist at Heidelberg University Hospital (UKHD). 

Flower stores, garden centers and nurseries throughout Germany are taking part in the campaign. For every flower or plant sold with the campaign label, a donation is made to KiTZ’s children’s cancer research. This year, “Give flowers. Spread hope.” is already celebrating its 5th anniversary. Over the past four years, participants have collected a total of around 367,000 euros to help children and young people with cancer.

This year, the proceeds from the campaign will go to the “EU CAN KIDS” alliance, in which the KiTZ cooperates with two of the most important children’s cancer centers in Europe, the Prinses Máxima Centrum in Utrecht and the French Institut Curie in Paris. With “EU CAN KIDS”, the three centers of excellence want to create better conditions for children with cancer in Europe so that all young patients have access to modern treatment methods.

This year’s campaign partners are once again the Fachverband Deutscher Floristen e.V. and Fleurop AG, which are supporting the campaign for the 5th time. “Fleurop is once again contributing to the campaign this year with its own bouquet,” says a delighted Nico Lamprecht, Marketing Manager at Fleurop AG. For every “charity bouquet” that can be ordered online from April to the end of June, two euros will be donated to children’s cancer research at KiTZ.

Klaus Götz, President of the Fachverband Deutscher Floristen e.V. Bundesverband (FDF) is also looking forward to the start of the campaign: “With flowers and plants, you can give affection and joy, as well as comfort and hope. The campaign is a great opportunity for the industry and for our members in the FDF to help seriously ill children and give them hope. That is why we are once again committed to supporting this campaign and are delighted to be involved again.” 

The preparations for the campaign were also supported by many different committed people and companies. “A lot of heart and soul goes into this campaign and it is only possible with a lot of voluntary support,” emphasizes campaign organizer Frederike Scheurer from KiTZ. “We are incredibly grateful to our partners and all our supporters, including over 60 flower wholesalers and retailers throughout Germany, who are making this campaign something very special. It is already a fantastic joint effort and we look forward to all florists and customers taking part!”

The participating stores and further information about the campaign can be found on the KiTZ website for anyone who would like to buy flowers for a good cause. On the Instagram profile of the KiTZ flower campaign, participating florists, gardeners and plant retailers can describe what moves them about childhood cancer and which floral creations they sell for the benefit of children during the campaign period. KiTZ also offers information on the development, diagnosis and treatment of childhood cancer and provides information on the research projects supported by the donations. 

KiTZ would like to thank all the companies that have made a significant contribution to raising awareness of the campaign with their donations in kind and time: Flugkraft – Fotoprojekt gegen Krebs gGmbH, Grafikbüro Köln GKB GmbH, Ströer Deutsche Städte Medien GmbH, Fachmagazin gestalten & verkaufen, Haymarket Media GmbH, Heidelberg Marriott Hotel. 

Our latest News

discover more
European Biotech Act: bioRN brings Industry and Policymakers together

European Biotech Act: bioRN brings Industry and Policymakers together

How can Europe strengthen its global competitiveness in biotechnology? Heidelberg, July 7th: This question was at the heart of a high-level roundtable hosted by the bioRN Life Science Cluster with Member of the European Parliament Hildegard Bentele. Representatives from Ascendis Pharma, BD, PROGEN, Novaliq, BASF Agricultural Solutions, PEPperPRINT, Evotec and Isenbruck Bösl Hörschler joined the […]

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp